AstraZeneca’s new global headquarters in Cambridge, UK is now estimated to cost $950 million. That is roughly twice the estimated cost when the project kicked-off several years ago. According to AZ’s latest annual report, the increased costs can be attributed to the complexity of the architecture, general inflation in construction costs and “increased investment in new technologies and equipment”. While occupancy of the new site was originally planned for 2016, the latest schedule has occupancy starting in 2020 with the site not being fully operational until after 2020. Learn More